Clients

Many companies has placed their trust in the high level of quality by Grifols Partnership.























The experiences of our clients



Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting.


"As a result of our new collaboration with Grifols, we anticipate that by the second half of 2014, we will be able to offer our customers in the U.S. the option of purchasing OFIRMEV® in flexible IV bags" said Ted Schroeder, President and CEO of Cadence.




Laboratorios Grifols and Mylan Institutional sign an agreement

Laboratorios Grifols and Mylan Institutional have recently signed a strategic third party manufacturing agreement that will help both companies to consolidate and expand its position in the hospital market.




Laboratorios Grifols sign an agreement with Eurospital

Laboratorios Grifols and Eurospital Company have recently signed a manufacturing and supply agreement for large volume parenteral solutions that will help both companies to consolidate and expand their leading position in the market. The experience and mutual trust has been the basis to define this collaboration.

 



Grifols Partnership and Laboratorios Grifols sign an agreement with Macopharma

Laboratorios Grifols has signed a new contract with Macopharma to manufacture washing solutions (1000ml and 600ml) and irrigation solutions in large volume bags (3000ml) for distribution in France, Belgium, Luxembourg, Holland, Germany, Austria, the UK and Ireland.

 

Macopharma has significantly expanded its infusion line in all of Europe since it first gained authorization in 1986 for this kind of product in the French market.